Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
9 Patents
#2 in Vadodara
#185 in India
Alembic Pharmaceuticals Limited
Forward Citations = 1
35 inventors:
Alembic Pharmaceuticals Limited
% Expired Patents = 66.7
EPO Patents = 3
Trademarks = 1
Forward Citations = 1
Loading Chart...
Loading Chart...
35 inventors (with patents filed for the assignee):
Chetan Patil (5 out of 5 patents)
Mahender Rao Siripragada (4 out of 6 patents)
Tejas Shah (3 out of 3 patents)
4. Mahendar Velisoju (3 out of 3 patents)
5. Vittal Tvsk (2 out of 2 patents)
6. Dinesh Chudasama (2 out of 2 patents)
7. Saisuryanarayana Donthukurthi (2 out of 2 patents)
8. Venkat Raman Jayaraman (2 out of 2 patents)
9. Dhiraj Rathod (2 out of 2 patents)
10. Vinayak Bhujade (2 out of 2 patents)
11. Irfan Vohra (2 out of 2 patents)
12. Viral Modi (2 out of 2 patents)
13. Mayur Budh (2 out of 2 patents)
14. Ojas Gandhi (2 out of 2 patents)
15. Samir Patel (2 out of 4 patents)
9 patents:
1. 11613540 - Solid state forms of Venetoclax and its process for the preparation there of (2023-03-28),
Company Overview
Alembic Pharmaceuticals Limited is one of the leading pharmaceutical companies in India. Established in 1907, the company has a strong presence in the domestic and international markets. Alembic is known for its high-quality generic and branded medicines across various therapeutic areas. The company is committed to innovation, research, and development to improve healthcare outcomes for patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alembic Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/alembic-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]